Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

POLLAR: Impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project
Jean Bousquet, Josep M. Antó, Isabella Annesi‐Maesano, et al.
Clinical and Translational Allergy (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 89

Showing 26-50 of 89 citing articles:

Manifesto on united airways diseases (UAD): an Interasma (global asthma association – GAA) document
Angélica Tiotiu, Plamena Novakova, Ilaria Baiardini, et al.
Journal of Asthma (2021) Vol. 59, Iss. 4, pp. 639-654
Open Access | Times Cited: 32
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities
Bernardo Sousa‐Pinto, Aram Antó, Markus Berger, et al.
Clinical and Translational Allergy (2022) Vol. 12, Iss. 11
Open Access | Times Cited: 21
Effects of pollen concentration on allergic rhinitis in children: A retrospective study from Beijing, a Chinese megacity
Yuxin Zhao, Zhaobin Sun, Li Xiang, et al.
Environmental Research (2023) Vol. 229, pp. 115903-115903
Closed Access | Times Cited: 12
Automatic market research of mobile health apps for the self‐management of allergic rhinitis
Aram Antó, Bernardo Sousa‐Pinto, Heather J. Zar, et al.
Clinical & Experimental Allergy (2022) Vol. 52, Iss. 10, pp. 1195-1207
Open Access | Times Cited: 16
Digitally‐enabled, person‐centred care (PCC) in allergen immunotherapy: An ARIA‐EAACI Position Paper
Oliver Pfaar, Bernardo Sousa‐Pinto, Nikolaos G. Papadopoulos, et al.
Allergy (2024) Vol. 79, Iss. 8, pp. 2037-2050
Open Access | Times Cited: 3
Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
Jean Bousquet, Holger J. Schünemann, Bernardo Sousa-Pinto, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 10, pp. 2648-2668.e2
Open Access | Times Cited: 3
A demonstration project of Global Alliance against Chronic Respiratory Diseases: Prediction of interactions between air pollution and allergen exposure—the Mobile Airways Sentinel NetworK-Impact of air POLLution on Asthma and Rhinitis approach
Mikhail Sofiev, Yuliia Palamarchuk, Annabelle Bédard, et al.
Chinese Medical Journal (2020) Vol. 133, Iss. 13, pp. 1561-1567
Open Access | Times Cited: 25
Digital transformation of health and care to sustain Planetary Health: The MASK proof-of-concept for airway diseases—POLLAR symposium under the auspices of Finland’s Presidency of the EU, 2019 and MACVIA-France, Global Alliance against Chronic Respiratory Diseases (GARD, WH0) demonstration project, Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing
Jean Bousquet, Josep M. Antó, Tari Haahtela, et al.
Clinical and Translational Allergy (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Google Trends and pollen concentrations in allergy and airway diseases in France
Jean Bousquet, Gabrielle L. Onorato, G. Oliver, et al.
Allergy (2019) Vol. 74, Iss. 10, pp. 1910-1919
Closed Access | Times Cited: 24
Règlement général sur la protection des données pour MASK-air® (application mobile rhinite et asthme)
Daniel Laune, S. Arnavielhe, F. Viart, et al.
Revue des Maladies Respiratoires (2019) Vol. 36, Iss. 9, pp. 1019-1031
Closed Access | Times Cited: 23
From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity
Jean Bousquet, Josep M. Antó, Claus Bachert, et al.
European Respiratory Journal (2019) Vol. 54, Iss. 6, pp. 1901023-1901023
Open Access | Times Cited: 22
Country activities of Global Alliance against Chronic Respiratory Diseases (GARD): focus presentations at the 11th GARD General Meeting, Brussels
Jean Bousquet, Yousser Mohammad, Anna Bedbrook, et al.
Journal of Thoracic Disease (2018) Vol. 10, Iss. 12, pp. 7064-7072
Open Access | Times Cited: 21
The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective
Jean Bousquet, Marek Jutel, Oliver Pfaar, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 5, pp. 1805-1812
Open Access | Times Cited: 16
Clinical trials in allergen immunotherapy in the age group of children and adolescents: current concepts and future needs
Oliver Pfaar, R. Gerth van Wijk, L. Klimek, et al.
Clinical and Translational Allergy (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 16
From MASK-air and SILAM to CATALYSE (Climate Action To Advance HeaLthY Societies in Europe)
Bernardo Sousa‐Pinto, Yuliia Palamarchuk, Lucas Leemann, et al.
Journal of Investigational Allergology and Clinical Immunology (2023) Vol. 34, Iss. 1, pp. 12-19
Open Access | Times Cited: 6
Electronic clinical decision support system (eCDSS) in the management of asthma: from theory to practice
Jean Bousquet
European Respiratory Journal (2019) Vol. 53, Iss. 4, pp. 1900339-1900339
Open Access | Times Cited: 15
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases—Meeting Report (Part 2)
Jean Bousquet, N. Pham‐Thi, Anna Bedbrook, et al.
Journal of Thoracic Disease (2019) Vol. 11, Iss. 9, pp. 4072-4084
Open Access | Times Cited: 14
A multidimensional human-centric framework for environmental intelligence: Air pollution and noise in smart cities
Andreas Bardoutsos, Gabriel Filios, Ioannis Katsidimas, et al.
(2020), pp. 155-164
Closed Access | Times Cited: 13
As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial
Torpong Thongngarm, Chamard Wongsa, Phichayut Phinyo, et al.
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 9, Iss. 3, pp. 1365-1373.e6
Closed Access | Times Cited: 13
Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms
Jean Bousquet, D Schröder-Bernhardi, Claus Bachert, et al.
Clinical & Experimental Allergy (2021) Vol. 51, Iss. 8, pp. 1033-1045
Open Access | Times Cited: 12
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases—Meeting Report (Part 1)
Jean Bousquet, N. Pham‐Thi, Anna Bedbrook, et al.
Journal of Thoracic Disease (2019) Vol. 11, Iss. 8, pp. 3633-3642
Open Access | Times Cited: 13
Highlights and recent developments in airway diseases in EAACI journals (2018)
Jean Bousquet, Cezmi A. Akdiş, Clive Grattan, et al.
Allergy (2019) Vol. 74, Iss. 12, pp. 2329-2341
Open Access | Times Cited: 13
ARIA masterclass 2018: From guidelines to real-life implementation
Peter W. Hellings, Sven Seys, G. Mariën, et al.
Rhinology Journal (2019)
Open Access | Times Cited: 12
Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air®
Jean Bousquet, Bernardo Sousa‐Pinto, Josep M. Antó, et al.
Clinical and Translational Allergy (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 1
2019 ARIA Care pathways for allergen immunotherapy
Jean Bousquet, Oliver Pfaar, Alkis Togias, et al.
Alergologia (2019) Vol. 4, Iss. 3, pp. 134-134
Open Access | Times Cited: 11

Scroll to top